Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Let's hope for the best with the EMA HQ relocation
BETonMACE is largely based in the EU and will be aiming for post-Phase 3 drug approval application to EMA (and hopefully FDA) in 2019, assuming a successful BETonMACE and according to current BETonMACE trial design/schedule.
